Compare GOOS & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GOOS | PACB |
|---|---|---|
| Founded | 1957 | 2000 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Laboratory Analytical Instruments |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 789.1M | 655.9M |
| IPO Year | 2016 | 2010 |
| Metric | GOOS | PACB |
|---|---|---|
| Price | $8.79 | $2.26 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 8 |
| Target Price | ★ $9.43 | $2.54 |
| AVG Volume (30 Days) | 893.3K | ★ 13.0M |
| Earning Date | 11-05-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $93,468,000.00 |
| Revenue This Year | $3.18 | N/A |
| Revenue Next Year | $4.02 | $16.01 |
| P/E Ratio | $75.22 | ★ N/A |
| Revenue Growth | N/A | ★ 3.04 |
| 52 Week Low | $7.36 | $1.07 |
| 52 Week High | $14.60 | $3.44 |
| Indicator | GOOS | PACB |
|---|---|---|
| Relative Strength Index (RSI) | 71.10 | 51.19 |
| Support Level | $8.75 | $1.27 |
| Resistance Level | $10.42 | $3.07 |
| Average True Range (ATR) | 0.35 | 0.30 |
| MACD | 0.11 | -0.02 |
| Stochastic Oscillator | 75.27 | 39.91 |
Canada Goose Holdings Inc is a Canada-based company that designs, manufactures, distributes, and retails premium outerwear for men, women, and children. It operates business through three segments namely, Wholesale; Direct to Consumer (DTC), and Other. The DTC segment, which is the key revenue driver, comprises sales through country-specific e-commerce platforms and its company-owned retail stores located in luxury shopping locations. The Wholesale segment comprises sales made to a mix of retailers and international distributors, who are partners that have exclusive rights to an entire market, and travel retail locations. Geographically, it has a presence in Canada, the United States, North America, Greater China, Asia-Pacific, and Europe, the Middle East, and Africa.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.